AEON Biopharma, Inc. Annual Depreciation, Depletion and Amortization in USD for 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
AEON Biopharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate for 2022.
  • AEON Biopharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $25K, unchanged year-over-year.
Depreciation, Depletion and Amortization, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $68K Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.